Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells

Journal of General Virology

Volumn 92, Issue 11, 2011, Pages 2620-2627

  Rashid, Nurshamimi Nor ^a,b   Yusof, Rohana ^b   Watson, Roger J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CALSENILIN; CELL PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLINE; LIN 54 PROTEIN; PROTEIN B MYB; PROTEIN E6; PROTEIN E7; PROTEIN P130; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONTROLLED STUDY; FEMALE; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CRK-ASSOCIATED SUBSTRATE PROTEIN; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KV CHANNEL-INTERACTING PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN MULTIMERIZATION; REPRESSOR PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 80053944058     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.035352-0     Document Type: Article

References (28)

1. Cheng, L., Rossi, F., Fang, W., Mori, T. & Cobrinik, D. (2000). Cdk2- dependent phosphorylation and functional inactivation of the pRBrelated p130 protein in pRB(2), p16INK4A(+) tumor cells. J Biol Chem 275, 30317-30325.
2. Cobrinik, D. (2005). Pocket proteins and cell cycle control. Oncogene 24, 2796-2809.
3. Doorbar, J. (2006). Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110, 525-541.
4. Genovese, N. J., Banerjee, N. S., Broker, T. R. & Chow, L. T. (2008). Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol 82, 4862- 4873.
5. Hall, A. H. S. & Alexander, K. A. (2003). RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 77, 6066-6069.
6. Harrison, M. M., Ceol, C. J., Lu, X. & Horvitz, H. R. (2006). Some C. elegans class B synthetic multivulva proteins encode a conserved LIN-35 Rb-containing complex distinct from a NuRD-like complex. Proc Natl Acad Sci U S A 103, 16782-16787.
7. Jiang, M. & Milner, J. (2002). Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21, 6041-6048.
8. Johung, K., Goodwin, E. C. & DiMaio, D. (2007). Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 81, 2102-2116.
9. Knight, A. S., Notaridou, M. & Watson, R. J. (2009). A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells. Oncogene 28, 1737-1747.
10. Korenjak, M., Taylor-Harding, B., Binne ́, U. K., Satterlee, J. S., Stevaux, O., Aasland, R., White-Cooper, H., Dyson, N. & Brehm, A. (2004). Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 119, 181-193.
11. Lam, E. W. & Watson, R. J. (1993). An E2F-binding site mediates cellcycle regulated repression of mouse B-myb transcription. EMBO J 12, 2705-2713.
12. Lam, E. W., Morris, J. D., Davies, R., Crook, T., Watson, R. J. & Vousden, K. H. (1994). HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J 13, 871-878.
13. Lewis, P. W., Beall, E. L., Fleischer, T. C., Georlette, D., Link, A. J. & Botchan, M. R. (2004). Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Genes Dev 18, 2929-2940.
14. Litovchick, L., Sadasivam, S., Florens, L., Zhu, X., Swanson, S. K., Velmurugan, S., Chen, R., Washburn, M. P., Liu, X. S. & DeCaprio, J. A. (2007). Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 26, 539-551.
15. McLaughlin-Drubin, M. E. & Mü nger, K. (2009). Oncogenic activities of human papillomaviruses. Virus Res 143, 195-208.
16. Osterloh, L., von Eyss, B., Schmit, F., Rein, L., Hübner, D., Samans, B., Hauser, S. & Gaubatz, S. (2007). The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis. EMBO J 26, 144-157.
17. Pilkinton, M., Sandoval, R. & Colamonici, O. R. (2007). Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex. Oncogene 26, 7535-7543.
18. Popov, B., Chang, L. S. & Serikov, V. (2005). Cell cycle-related transformation of the E2F4-p130 repressor complex. Biochem Biophys Res Commun 336, 762-769.
19. Rampias, T., Sasaki, C., Weinberger, P. & Psyrri, A. (2009). E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 101, 412- 423.
20. Saville, M. K. & Watson, R. J. (1998). The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties. Oncogene 17, 2679- 2689.
21. Schmit, F., Korenjak, M., Mannefeld, M., Schmitt, K., Franke, C., von Eyss, B., Gagrica, S., Hänel, F., Brehm, A. & Gaubatz, S. (2007). LINC, a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2/M genes. Cell Cycle 6, 1903-1913.
22. Sima, N., Wang, W., Kong, D., Deng, D., Xu, Q., Zhou, J., Xu, G.,Meng, L., Lu, Y. & other authors (2008). RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Apoptosis 13, 273-281.
23. Tang, S., Tao, M., McCoy, J. P., Jr & Zheng, Z. M. (2006). Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene 25, 2094-2104.
24. Tavner, F., Frampton, J. & Watson, R. J. (2007). Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells. Oncogene 26, 2727-2735.
25. Tschöp, K., Conery, A. R., Litovchick, L., Decaprio, J. A., Settleman, J., Harlow, E. & Dyson, N. (2011). A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev 25, 814-830.
26. Yamato, K., Yamada, T., Kizaki, M., Ui-Tei, K., Natori, Y., Fujino, M., Nishihara, T., Ikeda, Y., Nasu, Y. & &/x&&namegr type=editor&&name&&fname&other&/fname&&x& &/x&&sname&authors&/sname&&/name&&/namegr& (2008). New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther 15, 140-153.
27. Yugawa, T. & Kiyono, T. (2009). Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 19, 97-113.
28. Zhang, B., Chen, W. & Roman, A. (2006). The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci U S A 103, 437-442.